Carbon-13 Market Size Worth USD 125.72 Million BY 2032 | CAGR: 5.2%

The global carbon-13 market size is expected to reach USD 125.72 million by 2032, according to a new study by Polaris Market Research. The report “Carbon-13 Market Size, Share, Trends, Industry Analysis Report: By Purity (98%-99% and ＞99%); Application; End-user; and Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) – Market Forecast, 2024 - 2032.” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The primary driver of the carbon-13 market is the expanding use of nuclear magnetic resonance (NMR) spectroscopy, where Carbon-13 is essential for the detailed analysis of molecular structures. NMR spectroscopy relies on the magnetic properties of nuclei, and Carbon-13, with its nuclear spin properties, is particularly useful for providing detailed information about the structure, dynamics, reaction state, and chemical environment of molecules.

In addition to NMR spectroscopy, the healthcare sector is a major growth area for carbon-13. The isotope is increasingly used in non-invasive diagnostic procedures, such as breath tests, which are employed to diagnose various gastrointestinal disorders, including infections by Helicobacter pylori (H. pylori), which is linked to peptic ulcer disease and gastric cancer.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/carbon-13-market/request-for-sample

Technological advancements in production processes are expected to reduce costs over time, making carbon-13 more accessible to a broader range of users. Innovations in isotope separation techniques, as well as scaling up production capacities, may help alleviate some of the supply chain constraints and reduce the overall cost of carbon-13, thus expanding its market potential. Additionally, the expanding middle class and increasing healthcare spending are likely to boost the demand for advanced diagnostic tools, including those utilizing Carbon-13.

Carbon-13 Market Report Highlights

• The 98%-99% segment dominated the market in 2023 due to the expansion of applications in organic synthesis and materials science, where slightly lower purity levels suffice while still providing satisfactory results.
• The magnetic resonance imaging (MRI) segment is estimated to grow at the highest CAGR due to the expansion of healthcare infrastructure and technological advancements in imaging capabilities. Additionally, the rising prevalence of chronic diseases, alongside an aging population, significantly boosts the demand for effective imaging solutions such as MRI.
• North America dominated the carbon-13 market in 2023 due to the presence of advanced research institutions and pharmaceutical companies. Furthermore, the increasing emphasis on personalized medicine and advanced diagnostics has bolstered demand for carbon-13 in North America.
• The market in Asia Pacific is expected to expand at a high CAGR in the coming years owing to rapid industrialization and a growing emphasis on healthcare advancements. Additionally, significant government initiatives aimed at enhancing healthcare infrastructure are propelling the market.
• The global key market players include China Isotope & Radiation Corporation, Merck KGaA, Shanghai Chemical Industry Research Institute Co., Ltd., Cambridge Isotope Laboratories, Inc., Trace Sciences International, ISOFLEX, MedChemExpress, BuyIsotope, Avanti Polar Lipids, and Qmx Laboratories Ltd.

Polaris Market Research has segmented the carbon-13 market report based on purity, application, end user, and region:

By Purity Outlook (Revenue, USD million, 2020 - 2032)

• 98%-99%
• 99%.

By Application Outlook (Revenue, USD million, 2020 - 2032)

• Nuclear Magnetic Resonance (NMR) Spectroscopy
• Magnetic Resonance Imaging (MRI)
• Carbon Dating
• Breath Test
• Other

By End User Outlook (Revenue, USD million, 2020 - 2032)

• Healthcare
• Chemicals
• Academia and Research Institutions
• Environmental Agencies

By Regional Outlook (Revenue, USD million, 2020 - 2032)

• North America

• US
• Canada

• Europe

• Germany
• France
• UK
• Italy
• Spain
• Netherlands
• Russia
• Rest of Europe

• Asia Pacific

• China
•  Japan
•  India
•  Malaysia
•  South Korea
• Indonesia
• Australia
• Vietnam
•  Rest of Asia Pacific

• Middle East & Africa

• Saudi Arabia
• UAE
• Israel
• South Africa
• Rest of Middle East & Africa

• Latin America

• Mexico
• Brazil
• Argentina
• Rest of Latin America

Carbon-13 Report Scope